Search

everythinglearnresearchcommunity

for

Search:↓

IP-PA1 helps grow hair in mice and affects human cell growth-related genes differently than traditional hair growth treatments.

Researchers developed promising agents for prostate cancer imaging, with the best one showing high potential for clinical use.

Skin organoids can model tuberculosis infection and help test treatments.

Trichodysplasia spinulosa is a rare skin disease in immunocompromised patients caused by a specific virus targeting hair follicle cells.

Controlled microflora in animals delays immune cell maturation and affects immunity.

OR101 may effectively treat atopic dermatitis and similar skin conditions.

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.

Mouse hair follicle stem cells can help prevent Type 1 Diabetes.

Hydroxytyrosol helps reduce liver injury by blocking certain inflammation pathways.

CD1d expression in scalp skin and hair follicles changes with the hair cycle and may help protect against microbes.

Tofacitinib effectively reduces hair loss in children with alopecia areata but may cause mild side effects and relapses.

Overexpressing GLI-1 in mice skin can cause tumors like human basal cell carcinomas.

New treatments for immune disorders caused by FOXN1 deficiency are promising.

A pathway helps maintain long telomeres in both stem and cancer cells.

Tofacitinib may help regrow hair in alopecia areata patients.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

Blocking CRF1 receptors improved male hormone levels and reduced testicular tumor size in men with a specific adrenal condition.

A woman with alopecia regrew her hair after taking a higher dose of tocilizumab.

KRTAP2-3 could help predict cancer recurrence by identifying specific cancer cells.

Oral tofacitinib may be an effective and tolerable treatment for some people with severe alopecia areata.

Tofacitinib is effective and safe for treating alopecia areata with a good drug survival rate.

Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.

All-trans retinoic acid helps amelanotic melanocytes in hair follicles develop and produce pigment while reducing their growth.

Using finasteride with TIP extends time off period for prostate cancer patients.

Some patients developed hair loss after islet cell transplant possibly due to their immune-suppressing medications.

Too much IKZF1 and Ikaros protein may cause alopecia areata.

MILL molecules are unique immune proteins in mice that don't need TAP to appear on cell surfaces.

Tofacitinib significantly improved symptoms in a patient with overlapping autoimmune disorders.

CD10 helps distinguish between basal cell carcinoma and benign hair follicle tumors.

Tyrosine kinase inhibitors show promise in treating some skin diseases but their definitive role in dermatology is still unclear.